Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: Steve hoffmann who wrote (1418)	4/11/1999 5:25:00 PM
From: Kimberly Lee	Respond to of 108040

Steve, Hambrecht, Monty and Suntrust are decent underwriters. I just review some of the reports on ACDO from Goldman and BEST; the year to year topline and bottomline growth are impressive, 57% and 151% respectively, but can't find any sizzle in this company as yet. Some brief info on ACDO: Accredo Health, Incorporated 1640 Century Center Pkwy., Ste. 101 Memphis, TN 38134 Phone: 901-385-3688 Fax: 901-385-3776 Web Site: accredohealth.com IPO INFORMATION Filing date: September 1, 1998 Expected IPO date: TBA Exchange: Nasdaq Proposed ticker: ACDO Offering amount (mil.): $74.8 Underwriters: Hambrecht & Quist; NationsBanc Montgomery Securities LLC; Suntrust Equitable Securities KEY NUMBERS Fiscal Year-End: June 1998 Sales (mil.): $181.0 1-Yr. Sales Change: 57.1% 1998 Income (mil.): $2.8 1-Yr. Income Change: 151.4% Employees: 271 More Financials KEY PEOPLE CEO: David D. Stevens CFO: Joel R. Kimbrough HR: Jill Stem When a spoonful of sugar won't help the medicine go down, perhaps Accredo Health can help. Formerly known as Nova Factor, the company provides pharmacy and treatment program management for Gaucher's disease (a liver condition), hemophilia, multiple sclerosis, and Crohn's disease (an intestinal inflammation). Accredo delivers medications, assists with treatment programs, and provides payment claims processing services. But it is not a disinterested bystander. Most of its medications are made by single manufacturers (including Genzyme, Biogen, and Centocor) for which it provides consulting on pricing, packaging, and marketing. The company also seeks relationships with care providers (mostly in Texas) and payers.